| Metric | სს საერთაშორისო სამედიცინო ტექნოლოგიები | შპს BROTHERS | შპს ფარმაქსი |
|---|---|---|---|
| Growth | |||
| Revenue | ₾72.7m₾84.2m | ₾30.1m₾32.3m | ₾37.2m₾38.4m |
| Revenue growth | -13.7% | -6.8% | -2.9% |
| Profitability | |||
| EBITDA | ₾14.0m₾17.1m | -₾575k₾3.9m | ₾2.3m₾4.9m |
| EBITDA margin | 19.3%20.3% | -1.9%12.2% | 6.1%12.8% |
| Net profit | ₾13.3m₾17.3m | -₾4.4m | |
| ₾188k₾5.6m |
| Net margin | 18.3%20.5% | -14.6%30.5% | 0.5%14.6% |
| Balance sheet | |||
| Total assets | ₾8.9m₾12.3m | ₾36.8m₾38.8m | ₾53.9m₾85.6m |
| Total equity | ₾578k₾1.6m | -₾43.1m-₾38.7m | ₾17.6m₾28.0m |
| ROE | 2305.5%1074.7% | — | 1.1%20.0% |